EGFR and neoplasm: Therefore, EBP has become a promising vector for EGFR-targeting Gd chelates to improve the specificity and sensitivity of contrast-enhanced MRI in clinical tumor diagnosis, enabling the application of molecule-targeted drugs in vivo for noninvasive tumor subtyping and treatment.